These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30219761)

  • 1. Association of Medication Beliefs, Self-efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis.
    McCulley C; Katz P; Trupin L; Yelin EH; Barton JL
    J Rheumatol; 2018 Dec; 45(12):1636-1642. PubMed ID: 30219761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern.
    Cea-Calvo L; Raya E; Marras C; Salman-Monte TC; Ortiz A; Salvador G; Monteagudo I; Carmona L; Fernandez S; Arteaga MJ; Calvo-Allén J
    Rheumatol Int; 2018 Sep; 38(9):1735-1740. PubMed ID: 29959469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study.
    Kumar K; Raza K; Nightingale P; Horne R; Chapman S; Greenfield S; Gill P
    BMC Musculoskelet Disord; 2015 Dec; 16():396. PubMed ID: 26714853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study.
    Balsa A; García de Yébenes MJ; Carmona L;
    Ann Rheum Dis; 2022 Mar; 81(3):327-334. PubMed ID: 34844924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.
    Wei L; Champman S; Li X; Li X; Li S; Chen R; Bo N; Chater A; Horne R
    BMJ Open; 2017 Oct; 7(10):e017293. PubMed ID: 28982826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    J Manag Care Spec Pharm; 2015 May; 21(5):401-7. PubMed ID: 25943001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study.
    Brandstetter S; Riedelbeck G; Steinmann M; Loss J; Ehrenstein B; Apfelbacher C
    J Health Psychol; 2018 Aug; 23(9):1185-1195. PubMed ID: 27151068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.
    van den Bemt BJ; van den Hoogen FH; Benraad B; Hekster YA; van Riel PL; van Lankveld W
    J Rheumatol; 2009 Oct; 36(10):2164-70. PubMed ID: 19723906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.
    Smolen JS; Gladman D; McNeil HP; Mease PJ; Sieper J; Hojnik M; Nurwakagari P; Weinman J
    RMD Open; 2019; 5(1):e000585. PubMed ID: 30713716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a group-based intervention to change medication beliefs and improve medication adherence in patients with rheumatoid arthritis: a randomized controlled trial.
    Zwikker HE; van den Ende CH; van Lankveld WG; den Broeder AA; van den Hoogen FH; van de Mosselaar B; van Dulmen S; van den Bemt BJ
    Patient Educ Couns; 2014 Mar; 94(3):356-61. PubMed ID: 24388126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis.
    Neame R; Hammond A
    Rheumatology (Oxford); 2005 Jun; 44(6):762-7. PubMed ID: 15741193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.
    Morgan C; McBeth J; Cordingley L; Watson K; Hyrich KL; Symmons DP; Bruce IN
    Rheumatology (Oxford); 2015 Oct; 54(10):1780-91. PubMed ID: 25972390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study assessing the novel use of musculoskeletal ultrasound in patients with rheumatoid arthritis to improve patient attitudes and adherence to medication.
    Joplin SK; van der Zwan R; Bagga H; Joshua F; Wong PK
    Int J Rheum Dis; 2016 Jul; 19(7):658-64. PubMed ID: 24839920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence.
    van Heuckelum M; Linn AJ; Vandeberg L; Hebing RCF; van Dijk L; Vervloet M; Flendrie M; Nurmohamed MT; van Dulmen S; van den Bemt BJF; van den Ende CHM
    PLoS One; 2019; 14(8):e0221290. PubMed ID: 31469852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a narrative review of the literature.
    Salt E; Frazier SK
    Orthop Nurs; 2010; 29(4):260-75. PubMed ID: 20664466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Health Care Professionals' Implicit and Explicit Attitudes Toward Conventional Disease-Modifying Antirheumatic Drugs Associated With Those of Their Patients?
    van Heuckelum M; Hebing RCF; Vandeberg L; Linn AJ; Flendrie M; Nurmohamed MT; van Dulmen S; van den Ende CHM; van den Bemt BJF
    Arthritis Care Res (Hoboken); 2021 Mar; 73(3):364-373. PubMed ID: 32166901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.
    Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J
    Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.